Pressure Pain Threshold of Jaw Muscles in TMD Patients Submitted to a Conservative Treatment
Launched by FEDERAL UNIVERSITY OF SÃO PAULO · May 4, 2014
Trial Information
Current as of July 01, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • more than 18 years old have diagnosis of myofascial pain according RDC/TMD signed the informed consent
- Exclusion Criteria:
- • people under 18 years old
About Federal University Of São Paulo
The Federal University of São Paulo (Universidade Federal de São Paulo - UNIFESP) is a prestigious institution dedicated to advancing education, research, and healthcare in Brazil. Renowned for its commitment to innovation and excellence, UNIFESP plays a pivotal role in clinical research, focusing on a multidisciplinary approach to improve health outcomes. The university fosters collaboration among researchers, healthcare professionals, and community stakeholders, ensuring that clinical trials conducted under its auspices adhere to rigorous ethical standards and contribute valuable insights to the medical field. With a rich history of academic achievement and a strong emphasis on translational research, UNIFESP is a key player in the development of new therapies and medical interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Luis G Alonso, PhD
Study Chair
Federal University of São Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials